Akkermansia muciniphila derived tripeptide jams the gear of sepsis, inflammation and mortality
- PMID: 37857477
- DOI: 10.1136/gutjnl-2023-331092
Akkermansia muciniphila derived tripeptide jams the gear of sepsis, inflammation and mortality
Keywords: INFLAMMATION; SEPSIS.
Conflict of interest statement
Competing interests: PDC is inventor on patent applications dealing with the use of specific bacteria and components in the treatment of different diseases. PDC was cofounder of The Akkermansia Company SA and Enterosys S.A.
Comment on
-
Novel tripeptide RKH derived from Akkermansia muciniphila protects against lethal sepsis.Gut. 2023 Dec 7;73(1):78-91. doi: 10.1136/gutjnl-2023-329996. Gut. 2023. PMID: 37553229
Publication types
MeSH terms
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical